Drugs / CX-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02995655 | Apr 2017 → Sep 2018 | acute myeloid leukemia, myelodysplastic syndrome | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CX-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02995655 ↗ |